ET 007

Drug Profile

ET 007

Alternative Names: Anti-HIV drug - Endocrine Technology; HIV antiviral drug - Endocrine Transplant

Latest Information Update: 24 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Endocrine Technology LLC
  • Class
  • Mechanism of Action HIV envelope protein gp120 inhibitors; HIV envelope protein gp41 inhibitors; Human immunodeficiency virus tat gene product inhibitors; Immunostimulants; RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 24 Apr 2007 Discontinued - Preclinical for HIV infections prevention in USA (unspecified route)
  • 24 Apr 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
  • 18 Feb 2002 Preclinical development for HIV infections prevention in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top